Table 3 Spearman correlations (ρ) between donor oligotype profiles and patient samples.
Family | Donor | Administration | Time point (n)† | Average ± SEM |
|---|---|---|---|---|
Lachnospiraceae | 67 | cFMT | 3–14 days (15) | 0.278 ± 0.073 B |
cFMT | 15–35 days (8) | 0.282 ± 0.130 B | ||
eFMT | 3–14 days (4) | 0.483 ± 0.130 AB | ||
eFMT | 15–35 days (3) | 0.634 ± 0.013 A | ||
71 | cFMT | 3–14 days (12) | 0.296 ± 0.062 A | |
cFMT | 15–35 days (14) | 0.290 ± 0.056 A | ||
eFMT | 3–14 days (10) | 0.420 ± 0.033 A | ||
eFMT | 15–35 days (8) | 0.413 ± 0.050 A | ||
Bacteroidaceae | 67 | cFMT | 3–14 days (15) | 0.147 ± 0.084 A |
cFMT | 15–35 days (8) | 0.150 ± 0.122 A | ||
eFMT | 3–14 days (4) | 0.324 ± 0.209 A | ||
eFMT | 15–35 days (4) | 0.528 ± 0.184 A | ||
71 | cFMT | 3–14 days (10) | 0.311 ± 0.105 A | |
cFMT | 15–35 days (13) | 0.324 ± 0.093 A | ||
eFMT | 3–14 days (10) | 0.722 ± 0.093 B | ||
eFMT | 15–35 days (8) | 0.751 ± 0.041 B | ||
Porphyromonadaceae | 67 | cFMT | 3–14 days (12) | 0.308 ± 0.086 A |
cFMT | 15–35 days (4) | 0.522 ± 0.157 A | ||
eFMT | 3–14 days (4) | 0.445 ± 0.154 A | ||
eFMT | 15–35 days (3) | 0.634 ± 0.277 A | ||
71 | cFMT | 3–14 days (4) | -0.239 ± 0.146 C | |
cFMT | 15–35 days (9) | 0.108 ± 0.129 BC | ||
eFMT | 3–14 days (10) | 0.605 ± 0.207 AB | ||
eFMT | 15–35 days (8) | 0.733 ± 0.151 A |